Veena Fauble Selected Research

Hematopoietic Stem Cell Transplantation

1/2019

Comparison of reduced intensity conditioning regimens used in patients undergoing hematopoietic stem cell transplantation for myelofibrosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Veena Fauble Research Topics

Disease

3	Primary Myelofibrosis (Myelosclerosis) 01/2019 - 01/2014
3	Neoplasms (Cancer) 01/2018 - 09/2012
1	Eosinophilia 01/2018
1	Blast Crisis (Blast Phase) 09/2012

Drug/Important Bio-Agent (IBA)

1	Melphalan (Alkeran)FDA LinkGeneric 01/2019
1	Busulfan (Busulfex)FDA Link 01/2019
1	Carmustine (FIVB)FDA Link 01/2019
1	fludarabineIBA 01/2019
1	Urea (Carbamide)FDA LinkGeneric 01/2019
1	Tyrosine Kinase InhibitorsIBA 01/2018
1	Janus KinasesIBA 03/2016
1	Janus Kinase 1IBA 03/2016
1	Azacitidine (5 Azacytidine)FDA Link 01/2015
1	ABT-737IBA 01/2015
1	venetoclaxIBA 01/2015
1	ruxolitinibIBA 01/2014

Therapy/Procedure

2	Stem Cell Transplantation 01/2019 - 09/2012
2	Therapeutics 03/2016 - 01/2014
1	Hematopoietic Stem Cell Transplantation 01/2019
1	Cell Transplantation 03/2016